Growth Inhibition of Malignant Melanoma by Intermediate Frequency Alternating Electric Fields, and the Underlying Mechanisms
Overview
Affiliations
Objective: This study investigated the antitumour effects of intermediate frequency alternating electric fields (IF-AEF) in a murine melanoma cell line (B16F10) and a mouse tumour model.
Methods: IF-AEF was applied at 100 kHz. Proliferation of B16F10 cells in vitro was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. IF-AEF was applied in vivo to mice bearing B16F10 tumours. Terminal deoxy nucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) assay for apoptosis, and immunohistochemical detection of CD34 and vascular endothelial growth factor (VEGF), were performed.
Results: IF-AEF inhibited the proliferation of B16F10 cells in an electrical intensity and time-dependent manner. Treatment with IF-AEF for 7 days significantly inhibited the growth of tumours compared with untreated controls. IF-AEF induced apoptosis in vivo and reduced CD34-positive cell numbers; CD34 is a special marker of microvessel density.
Conclusion: IF-AEF reduced microvessel density related to tumour growth and may serve as a therapeutic strategy for cancer treatment.
Tumor-treating fields in cancer therapy: advances of cellular and molecular mechanisms.
Xiao T, Zheng H, Zu K, Yue Y, Wang Y Clin Transl Oncol. 2024; 27(1):1-14.
PMID: 38884919 DOI: 10.1007/s12094-024-03551-z.
Theory and application of TTFields in newly diagnosed glioblastoma.
Yu A, Zeng J, Yu J, Cao S, Li A CNS Neurosci Ther. 2024; 30(3):e14563.
PMID: 38481068 PMC: 10938032. DOI: 10.1111/cns.14563.
Tanzhu G, Chen L, Xiao G, Shi W, Peng H, Chen D Cell Death Discov. 2022; 8(1):416.
PMID: 36220835 PMC: 9553876. DOI: 10.1038/s41420-022-01206-y.
Tumor-Treating Fields in Glioblastomas: Past, Present, and Future.
Guo X, Yang X, Wu J, Yang H, Li Y, Li J Cancers (Basel). 2022; 14(15).
PMID: 35954334 PMC: 9367615. DOI: 10.3390/cancers14153669.
Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment.
Carrieri F, Smack C, Siddiqui I, Kleinberg L, Tran P Front Oncol. 2020; 10:575992.
PMID: 33215030 PMC: 7664989. DOI: 10.3389/fonc.2020.575992.